Trials that use: Fisher exact test
New to this method? Read the tutorial →
4,441 results
- A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2): Complete Statistical AnalysisIndependent statistical analysis of A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01385566).
- A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Intravenous Perampanel in Japanese Participants With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Perampanel in Japanese Participants With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03754582).
- A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease: primary endpoint results, effect estimate with confidence…
- A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B): Complete Statistical AnalysisIndependent statistical analysis of A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03073213).
- A Study of Ixekizumab in Participants With Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ixekizumab in Participants With Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02993471).
- A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers: Complete Statistical AnalysisIndependent statistical analysis of A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever: Complete Statistical AnalysisIndependent statistical analysis of A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04906980).
- A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy: primary endpoint results, effect estimate with confidence…
- A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Lasmiditan in Healthy Chinese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Lasmiditan in Healthy Chinese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04081324).
- A Study of Lasmiditan in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Lasmiditan in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03182920).
- A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Study of Loco-Regional Liposomal Bupivacaine Injection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Loco-Regional Liposomal Bupivacaine Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05992896).
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of LY2439821 in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2439821 in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01236118).
- A Study of LY2541546 in Healthy Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2541546 in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742078).
- A Study of LY2624803 in Japanese Participants With Transient Insomnia: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2624803 in Japanese Participants With Transient Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01784614).
- A Study of LY2928057 in Hemodialysis Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2928057 in Hemodialysis Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01991483).
- A Study of LY2940680 in Japanese Participants With Advanced Cancers: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2940680 in Japanese Participants With Advanced Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01919398).
- A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02188303).
- A Study of LY3006072 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3006072 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01640249).
- A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of LY3039478 in Participants With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3039478 in Participants With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01695005).
- A Study of LY3041658 in Adults With Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3041658 in Adults With Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04493502).
- A Study of LY3050258 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3050258 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02121834).
- A Study of LY3053102 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3053102 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01736241).
- A Study of LY3113593 in Participants With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3113593 in Participants With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02604160).
- A Study of LY3185643 and rGlucagon in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3185643 and rGlucagon in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02951780).
- A Study of LY3463251 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3463251 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03764774).
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of LY3526318 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3526318 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03977974).
- A Study of LY3832479 (LY-CoV016) in Healthy Participants 1: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3832479 (LY-CoV016) in Healthy Participants 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611789).
- A Study of LY900014 Formulations in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY900014 Formulations in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317575).
- A Study of LY900014 in Participants With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY900014 in Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin’s Lymphoma (NHL): Complete Statistical AnalysisIndependent statistical analysis of A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Complete Statistical AnalysisIndependent statistical analysis of A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma: primary endpoint results, effect estimate with confidence…
- A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children: Complete Statistical AnalysisIndependent statistical analysis of A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Management of Tarceva – Induced Rash in Patients With Non-Small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML: Complete Statistical AnalysisIndependent statistical analysis of A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…